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Association of CD and RA is widely described in adults,
but has never been reported in children with JIA. We
report a 13 years old girl with a 6 years history of polyar-
ticular JIA treated with Methotrexate (MTX) since diagno-
sis and after 2 years, in April 2004, started on etanercept.
On this treatment, patient presented important clinical
improvement which allowed steroids withdrawal and
progressive reduction of MTX. In June 2007 recurrent
attacks of migraine appeared with negative EEG and cere-
bral MRI. In November headache became continuous and
after one month morning palpebral oedema and right
chest pain appeared, followed by vomiting which lead to
hospitalisation in January 2008. Noticeable elements on
physical examination were: systolic hypertension, papille-
dema, palpebral and peripheral oedema, generalized lym-
phoadenopathy and hepatomegaly. Relevant lab tests
were: Hb 11.6 g/dL, ESR 67 mm/h, CRP 21.6 mg/L, hema-
turia, nephrotic proteinuria. Viral, bacterial and fungal
infections were ruled out. Cerebral MRI showed right emi-
sphere and right tentorial dural thickening (pachymenin-
gitis). CT and ultrasound confirmed the presence of
enlarged mediastinal and axillary lymph nodes, pericar-
dial and pleural effusion, bilateral renal enlargement and
ascites. Plasmocytosis was found on bone marrow aspi-
rate. Axillary lymph node biopsy was consistent with CD.
To our knowledge this the first report of the combination
of two conditions rarely associated with RA, multicentric
CD and pachymenigitis, in a child with JIA in remission
under treatment with etanercept. This raises the question
whether anti TNF-α therapy might contribute to lympho-
proliferation possibly via dysregulation of cytokines net-
work
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